CN110964759B - 一种抗心衰药物中间体的新合成工艺 - Google Patents
一种抗心衰药物中间体的新合成工艺 Download PDFInfo
- Publication number
- CN110964759B CN110964759B CN201811136200.4A CN201811136200A CN110964759B CN 110964759 B CN110964759 B CN 110964759B CN 201811136200 A CN201811136200 A CN 201811136200A CN 110964759 B CN110964759 B CN 110964759B
- Authority
- CN
- China
- Prior art keywords
- added
- novel synthesis
- synthesis process
- compound
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 11
- 230000015572 biosynthetic process Effects 0.000 title claims description 16
- 238000003786 synthesis reaction Methods 0.000 title claims description 16
- 206010019280 Heart failures Diseases 0.000 title abstract description 4
- 239000003814 drug Substances 0.000 title abstract description 4
- 229940079593 drug Drugs 0.000 title abstract description 4
- 108090000371 Esterases Proteins 0.000 claims abstract description 8
- 239000002904 solvent Substances 0.000 claims abstract description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- 229940125904 compound 1 Drugs 0.000 claims description 13
- 102000005158 Subtilisins Human genes 0.000 claims description 12
- 108010056079 Subtilisins Proteins 0.000 claims description 12
- 238000001308 synthesis method Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- 108090001060 Lipase Proteins 0.000 claims description 4
- 102000004882 Lipase Human genes 0.000 claims description 4
- 239000004367 Lipase Substances 0.000 claims description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 4
- 235000019421 lipase Nutrition 0.000 claims description 4
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 4
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 4
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000012074 organic phase Substances 0.000 description 18
- 238000004296 chiral HPLC Methods 0.000 description 13
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 239000007787 solid Substances 0.000 description 12
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 229940125782 compound 2 Drugs 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- OKDSPZRSANXDRL-BEFAXECRSA-N ethyl (2r,4s)-4-amino-2-methyl-5-(4-phenylphenyl)pentanoate Chemical compound C1=CC(C[C@@H](N)C[C@@H](C)C(=O)OCC)=CC=C1C1=CC=CC=C1 OKDSPZRSANXDRL-BEFAXECRSA-N 0.000 description 5
- 239000000337 buffer salt Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- LQVGFAZAFLLLQE-UHFFFAOYSA-N 4-amino-2-methylpentanoic acid Chemical compound CC(N)CC(C)C(O)=O LQVGFAZAFLLLQE-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- PYNXFZCZUAOOQC-UTKZUKDTSA-N sacubitril Chemical compound C1=CC(C[C@H](C[C@@H](C)C(=O)OCC)NC(=O)CCC(O)=O)=CC=C1C1=CC=CC=C1 PYNXFZCZUAOOQC-UTKZUKDTSA-N 0.000 description 1
- 229960003953 sacubitril Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/001—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by metabolizing one of the enantiomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811136200.4A CN110964759B (zh) | 2018-09-28 | 2018-09-28 | 一种抗心衰药物中间体的新合成工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811136200.4A CN110964759B (zh) | 2018-09-28 | 2018-09-28 | 一种抗心衰药物中间体的新合成工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110964759A CN110964759A (zh) | 2020-04-07 |
CN110964759B true CN110964759B (zh) | 2021-04-09 |
Family
ID=70026611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811136200.4A Active CN110964759B (zh) | 2018-09-28 | 2018-09-28 | 一种抗心衰药物中间体的新合成工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110964759B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106770855A (zh) * | 2016-12-30 | 2017-05-31 | 江苏开元医药化工有限公司 | 一种基于高效液相色谱法的沙库必曲中间体及其光学异构体的分离检测方法 |
CN106905192A (zh) * | 2017-03-09 | 2017-06-30 | 常州沃腾化工科技有限公司 | 一种沙库必曲中间体的纯化方法 |
WO2018116203A1 (en) * | 2016-12-23 | 2018-06-28 | Novartis Ag | New process for early sacubitril intermediates |
-
2018
- 2018-09-28 CN CN201811136200.4A patent/CN110964759B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018116203A1 (en) * | 2016-12-23 | 2018-06-28 | Novartis Ag | New process for early sacubitril intermediates |
CN106770855A (zh) * | 2016-12-30 | 2017-05-31 | 江苏开元医药化工有限公司 | 一种基于高效液相色谱法的沙库必曲中间体及其光学异构体的分离检测方法 |
CN106905192A (zh) * | 2017-03-09 | 2017-06-30 | 常州沃腾化工科技有限公司 | 一种沙库必曲中间体的纯化方法 |
Also Published As
Publication number | Publication date |
---|---|
CN110964759A (zh) | 2020-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200846307A (en) | Preparation of pregabalin and related compounds | |
MX2007012606A (es) | Proceso para elaborar (s)-pregabalina. | |
CN105063120B (zh) | 一种左乙拉西坦的制备方法 | |
SG178239A1 (en) | Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid | |
ZA200300005B (en) | 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof. | |
Hélaine et al. | Synthesis of 4, 4‐disubstituted L‐glutamic acids by enzymatic transamination | |
WO2020197875A1 (en) | D-metyrosine compositions and methods for preparing same | |
CN110964759B (zh) | 一种抗心衰药物中间体的新合成工艺 | |
RU2008109759A (ru) | Способ получения ангидрида трифторметансульфокислоты | |
US20210002207A1 (en) | A process for the preparation of Vigabatrin | |
US4183865A (en) | Process for the resolution of racemic α-aminonitriles | |
EP2801566A1 (en) | Process for the preparation of a viral protease inhibitor and its intermediates | |
WO2006080401A1 (ja) | フッ素化プロリン誘導体の製造方法 | |
CN107879925B (zh) | 一种高纯度高收率l-2-氯丙酸的合成方法 | |
CN109369442B (zh) | 一种β-N-甲氨基-L-丙氨酸的制备方法 | |
CN105439879B (zh) | 一种反式-4-二甲胺基巴豆酸盐酸盐的制备方法 | |
US7265238B2 (en) | Process for preparing methyl 4-(aminomethyl)benzoate | |
EA015420B1 (ru) | Способ получения r-энантиомера n-карбамоилметил-4-фенил-2-пирролидона | |
Larionov et al. | Practical Syntheses of Both Enantiomers of Cyclopropylglycine and of Methyl 2‐Cyclopropyl‐2‐N‐Boc‐iminoacetate | |
CN110963986B (zh) | 一种糖尿病治疗药物中间体的合成工艺 | |
CN104356155B (zh) | 一种(s)‑叔丁基二甲基硅氧基‑戊二酸单酰胺的制备方法 | |
JP2019167317A (ja) | L−カルノシン誘導体及びl−カルノシンの製造方法 | |
US5969179A (en) | Method for preparing enantiomeric forms of amino alkylaminophenyl propanoic acid | |
CN113527108A (zh) | 一种制备光学纯的5,7-二氟-1,2,3,4-四氢化萘-2-胺及其盐的方法 | |
CN113881720A (zh) | 一种转氨酶及使用其进行催化制备的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 102200 room 108, 1st floor, building 3, No. 11, Chaoqian Road, science and Technology Park, Changping District, Beijing Patentee after: Beijing Lingke Biotechnology Co.,Ltd. Country or region after: China Address before: 102200 room 108, 1st floor, building 3, No. 11, Chaoqian Road, science and Technology Park, Changping District, Beijing Patentee before: Beijing ruilaiboji Pharmaceutical Technology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240710 Address after: Room 1110, Building B, Huadi Financial Center, No. 267 Qianshan Road, Shushan District, Hefei City, Anhui Province, China 230000 Patentee after: Hefei Yuanfengshun Pharmaceutical Technology Co.,Ltd. Country or region after: China Address before: 102200 room 108, 1st floor, building 3, No. 11, Chaoqian Road, science and Technology Park, Changping District, Beijing Patentee before: Beijing Lingke Biotechnology Co.,Ltd. Country or region before: China |